Charity Scripture

Insider Reports History

Reporting-owner location: Houston, TX
Latest reporting-owner signature: Charity Scripture
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Charity Scripture

Form 4 holding Chief Development Officer

BELLICUM PHARMACEUTICALS, INC

Security class: Stock Option (right to buy)
Shares / value: 250,000
Estimated value
Report date: 15 Aug 2022
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Insider Reports Filed by Charity Scripture

4

BELLICUM PHARMACEUTICALS, INC

Report period: 15 Aug 2022
Transactions: 1
Transaction value: +$360,000
Accepted by SEC: 16 Aug 2022, 17:04
Role: Chief Development Officer
Next action: Open filing details

4

BELLICUM PHARMACEUTICALS, INC

Report period: 01 Dec 2021
Transactions: 1
Transaction value: +$259,500
Accepted by SEC: 02 Dec 2021, 14:23
Role: Chief Development Officer
Next action: Open filing details

3

BELLICUM PHARMACEUTICALS, INC

Report period: 01 Dec 2021
Transactions: 0
Transaction value: $0
Accepted by SEC: 02 Dec 2021, 14:21
Role: Chief Development Officer
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .